Judge Kacsmaryk’s decision to pause the FDA’s approval of the abortion pill mifepristone reads as ideological and extreme, according to legal and medical experts.
Related Articles
-
FDA advisers to discuss next round of Covid boosters for the fall
Food and Drug Administration advisers will meet Thursday to discuss how the next round of Covid boosters should be...
-
As nation’s largest school district reopens, health screening site crashes
A majority of New York City public school students returned for in-person learning Monday for the first time in...
-
Queen Elizabeth and husband, Prince Philip, receive coronavirus vaccine
LONDON — Britain’s Queen Elizabeth II, 94, and her husband Prince Philip, 99, have received vaccines against the coronavirus,...
-
Marijuana use during pregnancy linked to low birth weight, study finds
Women who use marijuana during pregnancy may be putting their babies’ health at risk, with risk increasing as use...
-
Report finds Nestlé adds sugars to baby food in low-income countries
In Switzerland, the label of Nestlé’s Cerelac baby cereal says it contains “no added sugar.” But in Senegal and...
-
Drinking coffee may be linked to lower risk of death, even with a little sugar
Contrary to popular myth, forgoing coffee isn’t likely to improve your health. The opposite might be true: Years of...
-
What a Kamala Harris presidency would mean for health care in America
WASHINGTON — A Kamala Harris presidency could have far-reaching consequences for the U.S. health care system, from abortion rights...
-
‘Deny, deny, deny’: By repeatedly rejecting claims, Medicare Advantage plans threaten rural hospitals and patients, say CEOs
For decades, Rose Stone counted on the Alliance HealthCare System in rural Holly Springs, Mississippi, for her medical needs....
Recent Comments